APA (7th ed.) Citation

Liang, Q., Li, Q., Chen, Z., Lv, L., Lin, Y., Jiang, H., . . . Xu, Q. (2024). Anemoside B4, a new pyruvate carboxylase inhibitor, alleviates colitis by reprogramming macrophage function. Inflammation research, 73(3), 345-362. https://doi.org/10.1007/s00011-023-01840-x

Chicago Style (17th ed.) Citation

Liang, Qing-hua, et al. "Anemoside B4, a New Pyruvate Carboxylase Inhibitor, Alleviates Colitis by Reprogramming Macrophage Function." Inflammation Research 73, no. 3 (2024): 345-362. https://doi.org/10.1007/s00011-023-01840-x.

MLA (9th ed.) Citation

Liang, Qing-hua, et al. "Anemoside B4, a New Pyruvate Carboxylase Inhibitor, Alleviates Colitis by Reprogramming Macrophage Function." Inflammation Research, vol. 73, no. 3, 2024, pp. 345-362, https://doi.org/10.1007/s00011-023-01840-x.